Print

Lay Description

To determine the difference in time to recovery and healing of monkey pox lesions between people receiving Tecovirimat and those receiving placebo. People with severe cases of monkeypox will receive Tecovirimat and not placebo.

Category

  • Skin Conditions
IRB Number
20220654HU
NCT Number
ct.gov registration not required
Open to Enrollment
Yes

Eligibility

Eligible Ages
18-99
Eligible Genders
All
Accepts Healthy Volunteers

Inclusion Criteria

Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion

Exclusion Criteria

Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion

Study Design

Arm Groups

Study Contact


Regulatory Point of Contact
Thomas Patterson
(210) 567-4666
patterson@uthscsa.edu

Regulatory Point of Contact
Irma Scholler
+1 (210) 450-3150
scholler@uthscsa.edu

Regulatory Point of Contact
Robin Tragus
(210) 567-5262
tragus@uthscsa.edu

Local Recruitment Point of Contact
Thomas Patterson
(210) 567-4666
patterson@uthscsa.edu

Local Recruitment Point of Contact
Robin Tragus
(210) 567-5262
tragus@uthscsa.edu

Principal Investigator
Thomas Patterson